CIBUS INC (CBUS) Stock News
NASDAQ:CBUS - Nasdaq - US17166A1016 - Common Stock - Currency: USD
CBUS Latest News, Press Relases and Analysis
Here are the top movers in Thursday's session.
Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Here are the top movers in Thursday's session.
Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Cibus, Inc. Announces Closing of $27.5 Million Public Offering
Cibus, Inc. Announces Closing of $27.5 Million Public Offering
SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that...
USDA Designates Cibus’ Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA’s Biotechnology Regulations
This action follows the USDA’s recent designation of Cibus’ disease resistance traits in Canola as not regulated, continuing Cibus’ product development momentum in the globally important Canola crop
USDA Designates Cibus’ Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA’s Biotechnology Regulations
This action follows the USDA’s recent designation of Cibus’ disease resistance traits in Canola as not regulated, continuing Cibus’ product development...
Which stocks are gapping on Thursday?
The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
These stocks are moving in today's pre-market session
The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Cibus, Inc. Announces Pricing of $27.5 Million Public Offering
Cibus, Inc. Announces Pricing of $27.5 Million Public Offering
SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that...
Stay updated with the stocks that are on the move in today's after-hours session.
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
Cibus, Inc. Announces Proposed Public Offering
Cibus, Inc. Announces Proposed Public Offering
SAN DIEGO, June 04, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that...
Cibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside Chat
Cibus Provides Webcast of BofA Securities AgTech Virtual Conference Fireside Chat
SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the
Cibus to Participate in Alliance Global Partner’s Annual Virtual Healthcare Company Showcase
Cibus to Participate in Alliance Global Partner’s Annual Virtual Healthcare Company Showcase
SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the
Cibus (CBUS) Reports Q1 Loss, Misses Revenue Estimates
Cibus (CBUS) delivered earnings and revenue surprises of -5.71% and 12.37%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: BIOX
Cibus Reports First Quarter Financial Results and Provides Year-to-Date Business Update for 2025
Ecuador Approves Cibus Herbicide Tolerance Traits as Equivalent to Conventional Breeding
Designation confirms conventional regulation of Cibus herbicide tolerance traits in Rice in Ecuador paving the way for further product development and eventual commercialization in a key Rice growing region
Ecuador Approves Cibus Herbicide Tolerance Traits as Equivalent to Conventional Breeding
Designation confirms conventional regulation of Cibus herbicide tolerance traits in Rice in Ecuador paving the way for further product development and...
Will Cadiz (CDZI) Report Negative Q1 Earnings? What You Should Know
Cadiz (CDZI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: CDZI
Cibus (CBUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Cibus (CBUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: CTVA
Matthews International (MATW) Lags Q2 Earnings and Revenue Estimates
Matthews International (MATW) delivered earnings and revenue surprises of -5.56% and 1.79%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MATW
Cibus to Report First Quarter 2025 Financial Results on May 8, 2025 After the Market Close and Host Conference Call
SAN DIEGO, April 25, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing...
USDA-APHIS Designates Additional Cibus’ Disease Resistance Trait Products as Not Regulated
Designation confirms conventional regulation of Cibus traits in the U.S. as modernized regulatory policy for precision gene editing breeding technologies continues to advance globally
USDA-APHIS Designates Additional Cibus’ Disease Resistance Trait Products as Not Regulated
Designation confirms conventional regulation of Cibus traits in the U.S. as modernized regulatory policy for precision gene editing breeding technologies...
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
A major milestone on March 14th 2025 advanced the EU Trilogue discussions aimed to complete the final text of the New Genomic Techniques (NGTs) or gene...
Cibus Welcomes the European Union’s Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward
Legislation aims to adapt EU law to reflect scientific and technological progress, enabling the products of New Genomic Techniques (NGTs), such as gene...